Australian Clinical Labs Ltd (AU:ACL) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Australian Clinical Labs Ltd has announced a daily buy-back of its ordinary fully paid securities, acquiring 125,000 shares on the previous day. This move is part of an ongoing buy-back strategy, with the company having repurchased a total of 1,080,864 shares before the previous day. Investors may find this buy-back activity indicative of the company’s confidence in its stock value.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.